文献速递细菌感染、耐药与抗菌药物

英国抗菌化学治疗学会先锋系列:为何培养对应对抗生素耐药至关重要

BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

本文指出抗生素处方与使用属于社会过程,尽管已有优化用药的指南与政策,挑战仍多。抗菌药物耐药研究多聚焦新药,但感染与抗生素使用的社会文化及社会经济驱动因素同样重要,需与终端用户共同开发情境化方案并具备可扩展性。必须承认并消除全球南北在资金、知识生成、所有权与转移上的不平等,通过本土能力建设实现可持续研究、公平代表与研究者职业发展。

要点

  • 抗生素处方与使用是社會过程,优化用药面临诸多挑战。
  • 抗菌药物耐药研究需关注社会文化与社会经济驱动因素。
  • 需与终端用户共同开发情境化方案,并消除全球南北不平等。

核心结论

  • 抗生素处方与使用是社會过程,尽管已有优化用药的指南与政策,许多挑战依然存在。
  • 抗菌药物耐药研究多聚焦新药,但感染与抗生素使用的社会文化及社会经济驱动因素同样重要。
  • 需与终端用户共同开发情境化方案,并使干预措施具备可扩展至不同环境的潜力。
  • 必须承认并消除全球南北在资金、知识生成、所有权与转移上的不平等。
  • 平衡资金与公平需开展本土能力建设,包括可持续研究、公平代表与研究者职业发展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Research has demonstrated that antibiotic prescribing and use are social processes. Despite the availability of guidelines and policies for optimized use, many challenges remain. Whilst much of the research in antimicrobial resistance is focused on new drugs, the socio-cultural and socio-economic drivers for infections and antibiotic use are also important considerations. Context-specific solutions that are co-developed with end users are needed if we are to optimize the use of existing and new antibiotics. The threat of antimicrobial resistance is not subject to geographical boundaries, and to truly be effective, interventions need to have the potential to be scaled to different settings. The inequities in funding, knowledge generation, ownership and transfer between the global North and South must be acknowledged and eradicated. Striking a balance in funding and equity requires in-country capacity building for: (i) delivering sustainable research; (ii) assuring equitable representation in research outputs; and (iii) supporting career progression of researchers through further funding, to support the generation of locally owned knowledge that contributes to optimized healthcare systems and translation into clinical practice.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Charani E. BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance. J Antimicrob Chemother. 2022. PMID: 35383371. doi:10.1093/jac/dkac077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。